CREATE Medicines to Host Investor and Partnering Meetings at the 2026 Jefferies Global Healthcare Conference in London
Discussions will highlight progress from CREATE's four clinical-stage in vivo CAR programs across autoimmune disease and oncology CAMBRIDGE, Mass., Nov. 6,